FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Julian Strange

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Phenomena

Blotting, Western

Procedures

Immunohistochemistry

Co-author Network

Publications

TOP 3
Mark A Westwood; Farrukh T Shah; Lisa J Anderson; Julian W Strange; Mark A Tanner; Alicia M Maceira; Jo Howard; John B Porter; J Malcolm Walker; Beatrix Wonke; Dudley J Pennell
Myocardial tissue characterization and the role of chronic anemia in sickle cell cardiomyopathy.
John Wharton; Julian W Strange; Gigi M O Møller; Ellena J Growcott; Xiaohui Ren; Angela P Franklyn; Stephen C Phillips; Martin R Wilkins
Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells.
Martin R Wilkins; Gideon A Paul; Julian W Strange; Nina Tunariu; Wendy Gin-Sing; Winston A Banya; Mark A Westwood; Alexander Stefanidis; Leong L Ng; Dudley J Pennell; Raad H Mohiaddin; Petros Nihoyannopoulos; J Simon R Gibbs
Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Julian Strange (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Mark A Westwood; Farrukh T Shah; Lisa J Anderson; Julian W Strange; Mark A Tanner; Alicia M Maceira; Jo Howard; John B Porter; J Malcolm Walker; Beatrix Wonke; Dudley J Pennell
Myocardial tissue characterization and the role of chronic anemia in sickle cell cardiomyopathy.
Journal of magnetic resonance imaging : JMRI 2007;26(3):564-8.
2005: John Wharton; Julian W Strange; Gigi M O Møller; Ellena J Growcott; Xiaohui Ren; Angela P Franklyn; Stephen C Phillips; Martin R Wilkins
Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells.
American journal of respiratory and critical care medicine 2005;172(1):105-13.
2005: Martin R Wilkins; Gideon A Paul; Julian W Strange; Nina Tunariu; Wendy Gin-Sing; Winston A Banya; Mark A Westwood; Alexander Stefanidis; Leong L Ng; Dudley J Pennell; Raad H Mohiaddin; Petros Nihoyannopoulos; J Simon R Gibbs
Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study.
American journal of respiratory and critical care medicine 2005;171(11):1292-7.
2003: A Sebkhi; Julian W Strange; Steven C Phillips; John Wharton; Martin R Wilkins
Phosphodiesterase type 5 as a target for the treatment of hypoxia-induced pulmonary hypertension.
Circulation 2003;107(25):3230-5.
2003: Lan Zhao; Nicola A Mason; Julian W Strange; Hamish Walker; Martin R Wilkins
Beneficial effects of phosphodiesterase 5 inhibition in pulmonary hypertension are influenced by natriuretic Peptide activity.
Circulation 2003;107(2):234-7.
2002: Julian W Strange; John Wharton; Peter G Phillips; Martin R Wilkins
Recent insights into the pathogenesis and therapeutics of pulmonary hypertension.
Clinical science (London, England : 1979) 2002;102(3):253-68.